---
title: CDMO Daily News — September 24, 2026
slug: daily-news-2026-09-24-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: September 24 CDMO daily: Sanner Completes Gilero Rebranding, Expands Chicago Innovation Facility; Cellares Partners with Seoul National University Hospital on…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-09-24-cdmo
published_at: 2026-09-24T00:00:32.644Z
last_updated: 2026-09-24T00:01:18.757Z
---

### [Sanner](/companies/sanner) Completes [Gilero](/companies/gilero) Rebranding, Expands Chicago Innovation Facility
- [Sanner](/companies/sanner) unified its North American operations under a single brand following its 2024 acquisition of [Gilero](/companies/gilero), consolidating medical device development, engineering, and pharmaceutical packaging expertise.
- The company expanded its Chicago facility with human factors laboratory, 3D printing, prototyping capabilities, and partnership access to mHUB Innovation Center to accelerate product development.

**Operational Impact**

The Chicago facility expansion adds dedicated human factors and rapid-prototyping capacity in a major medtech hub, enabling [Sanner](/companies/sanner) to reduce technology-transfer risk and accelerate time-to-market for device and pharmaceutical packaging customers.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/sanner-rebrands-gilero-expands-chicago-facility)*

---

### [Cellares](/companies/cellares) Partners with Seoul National University Hospital on Automated Cell Therapy Manufacturing
- [Cellares](/companies/cellares) will transfer SNUH's gene-modified hematopoietic stem cell therapy manufacturing process to its Cell Shuttle automated platform, including electroporation workflows.
- The proof-of-concept collaboration supports preclinical development and IND-enabling manufacturing for SNUH's paroxysmal nocturnal hemoglobinuria program ahead of U.S. clinical trials.
- Partnership marks Cellares' second Asia collaboration and expands its APAC footprint while addressing scalability and manufacturing reliability challenges in cell therapy production.

**Operational Impact**

[Cellares](/companies/cellares)' Seoul partnership validates its Cell Shuttle platform for complex autologous cell therapy workflows and establishes a second APAC manufacturing reference that may accelerate adoption among other sponsors preparing gene-modified HSPC programs for clinical translation.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/cellares-snuh-partner-on-cell-therapy-manufacturing)*

## References

1. [Contract Pharma Breaking News RSS — Sanner Completes Gilero Rebranding, Expands Chicago Innovation Facility](https://www.contractpharma.com/breaking-news/sanner-rebrands-gilero-expands-chicago-facility)
2. [Contract Pharma Breaking News RSS — Cellares Partners with Seoul National University Hospital on Automated Cell Therapy ](https://www.contractpharma.com/breaking-news/cellares-snuh-partner-on-cell-therapy-manufacturing)

Source: https://www.cdmo.directory/posts/daily-news-2026-09-24-cdmo